King to host his first official event since cancer treatment side effects
The King will attend his first public engagement since his short hospital stay following cancer treatment side effects when ...
Inquirer Opinion1d
Lifelong itch
My first experience with the condition was in my third year in high school. It started as subtle red bumps along my hairline, ...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
LIVMARLI Now Approved in Japan for ALGS and PFIC
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...
Urgent warning over antibiotic-resistant ‘super’ STI that could soon become ‘untreatable’
HEALTH bosses have issued an urgent warning over an “extensively drug resistant” STI, for fears it could soon become ...
A much-less talked about sign of diabetes is…
According to Kanikka Malhotra, Consultant Dietician and Diabetes Educator, genital itching can be an early warning sign of ...
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
FDA approves new medication for urinary tract infections
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Medscape6d
Nemolizumab Shows Lasting Benefits in Prurigo Nodularis
Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...
Understanding the different types of eczema and how to tackle them
Learn about different types of eczema, symptoms, treatment options, and how to differentiate from other skin conditions.
Pfizer introduces two novel therapies to treat patients across the atopic dermatitis disease spectrum
PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...